Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients
- 1 September 2013
- journal article
- Published by Future Medicine Ltd in Future Oncology
- Vol. 9 (9), 1307-1313
- https://doi.org/10.2217/fon.13.111
Abstract
Lung cancer therapies during the last decade have focused on targeting the genome of cancer cells, and novel routes for administering lung cancer therapies have been investigated for decades. Aerosol therapies for several systematic diseases and systemic infections were introduced into the market a decade ago. One of the main issues of aerosol therapies has been the ability to investigate the deposition of a drug compound throughout the systematic circulation and lymph node circulation. Until now, none of the published studies have efficiently shown the deposition of a chemotherapy pharmaceutical within the lymph node tissue. In our current work we present, for the first time, with the novel CytoViva® (AL, USA) technique, the deposition of cisplatin aerosol therapy in surgically resected stage II lymph nodes from lung cancer patients. Finally, we present the distribution of cisplatin in correlation with the cisplatin concentration in different lymph stations and comment on the possible mechanisms of distribution.Keywords
This publication has 27 references indexed in Scilit:
- Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with rendu‐osler diseaseThe Laryngoscope, 2012
- Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety StudyJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2011
- Feasibility and effectiveness of inhaled carboplatin in NSCLC patientsInvestigational New Drugs, 2011
- Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung CancerClinical Cancer Research, 2010
- The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalationBiomaterials, 2009
- Feasibility and Safety of Targeted Cisplatin Delivery to a Select Lung Lobe in Dogs via the AeroProbe®Intracorporeal Nebulization CatheterJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the LungClinical Cancer Research, 2007
- Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the LungsClinical Cancer Research, 2007
- Assessing a System to Capture Stray Aerosol during Inhalation of Nebulized Liposomal CisplatinJournal of Aerosol Medicine, 2006
- Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549Journal of Pharmacy and Pharmacology, 2006